Ind Swift Laboratories opened higher at ₹363.50, compared with its previous close of ₹361.05. During today's session, the stock has traded between ₹345.00 and ₹367.25, with an average traded price of ₹354.67. It is currently showing a sideways intraday trend.
An investment of ₹10,000 made 5 years ago in Ind Swift Laboratories is now worth
₹ 56,638.00
giving a profit of
₹ 46,638.00 (466.38%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
+0.30 (+0.08%)
Day High
₹367.25
Day Low
₹345.00
Day Open
₹363.50
Prev Close
₹361.05
Volume
3,65,436
Value Traded
₹12.96 Cr
1W Return
-6.33%
1M Return
-6.23%
3M Return
46.63%
6M Return
157.06%
1Y Return
245.03%
Market Cap (₹ Cr.)
3,142
PE Ratio
54.80
PB Ratio
2.27
Dividend Yield
-
ROE
3.11%
ROCE
3.68%
Book Value (₹)
159.06
Face Value (₹)
10.00
EPS (TTM)
2.84
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
-6.33%
6 Week
-
1 Month
-6.23%
3 Month
46.63%
9 Month
298.01%
Ind-Swift Laboratories passes all four resolutions at 31st AGM
All four resolutions passed at Ind-Swift Laboratories' 31st AGM held on September 30, 2026. Re-appointment of Navrattan Munjal saw 60,111 dissenting votes, primarily from public institutions. Appointment of Amit Mathur as independent director approved via special resolution. Total shares voted represented 47.61% of outstanding equity.
8 days agoEssix Biosciences acquires 70 lakh warrants in Ind-Swift Laboratories
Essix Biosciences acquired 70,00,000 FCWs on September 17, 2026. Promoter group diluted stake rises to 47.18% from 43.06%. Total diluted capital increases to 9,39,61,558 shares. Warrants are convertible into equity shares of ₹10 face value.
21 days agoInd-Swift Laboratories holds 31st AGM on September 30, 2026
Ind-Swift Laboratories holds its 31st AGM on September 30, 2026, via VC/OAVM. Remote e-voting is open from September 27 to September 29, 2026. Agenda includes adoption of FY26 financials and re-appointment of Chairman Navrattan Munjal. Appointment of Amit Mathur as Independent Director for a five-year term. Cost auditor remuneration for FY27 capped at ₹2 lakh plus taxes.
1mo agoInd-Swift Laboratories fixes warrant issue price at ₹196
Ind-Swift Laboratories fixes warrant issue price at ₹196 each. Regulatory floor price determined at ₹195.98 based on 10-day VWAP. Independent valuer estimated warrant value at ₹189.46. Price approved by Preferential Issue Committee on September 4, 2026.
1mo agoInd-Swift Labs guides for ₹900 crore FY27 revenue, 18%+ EBITDA
Ind-Swift Laboratories guides for ₹900 crore revenue in FY27. Management targets sustainable EBITDA margins of over 18% for FY27. Long-term roadmap includes ₹1,500 crore revenue target for FY30. Company aims for ₹200 crore profit after tax by FY30.
1mo agoInd-Swift Laboratories Q1FY27 PAT up 2.04x to ₹24.68 crore; CDMO details
Ind-Swift Laboratories posted a 2.04x YoY PAT increase to ₹24.68 crore in Q1FY27, driven by a 1,258 bps EBITDA margin expansion to 17.91%. Management clarified that the new Viatris CDMO deal contributed ₹5-6 crore initially, with full ₹200-220 crore run-rate expected over two years. The company plans to deploy ₹250 crore in cash reserves for capex over 2.5 years.
1mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹1,770.70 | +0.61% | ₹4,24,850.24 | 34.83 | +5.97% | |
| ₹9,285.00 | -1.50% | ₹2,46,487.58 | 85.12 | +43.41% | |
| ₹4,642.90 | -0.84% | ₹1,76,600.99 | 82.55 | +31.42% | |
| ₹1,132.50 | -0.17% | ₹1,12,967.31 | 24.74 | +14.00% | |
| ₹2,059.40 | -0.47% | ₹1,11,271.90 | 102.63 | +134.89% | |
| ₹1,329.60 | +1.40% | ₹1,07,412.86 | 31.62 | -14.87% | |
| ₹1,240.00 | +0.86% | ₹1,03,500.36 | 32.26 | -1.93% | |
| ₹2,372.00 | -1.17% | ₹97,974.30 | 47.92 | -3.57% | |
| ₹1,684.60 | -1.31% | ₹96,928.16 | 26.40 | +49.04% | |
| ₹1,953.60 | +0.96% | ₹89,336.17 | 16.03 | -0.29% | |
| ₹2,265.30 | -0.78% | ₹63,932.35 | 35.82 | +16.81% | |
| ₹5,250.00 | +0.86% | ₹62,771.63 | 28.34 | -3.75% |
An investment of ₹10,000 made 5 years ago in Ind Swift Laboratories is now worth
₹ 56,638.00
giving a profit of
₹ 46,638.00 (466.38%)
Note: Past profits do not guarantee future returns.
